DDR2 and breast neoplasm: (84) identified that epithelial-mesenchymal transition-mediated recurrent breast tumors upregulate the discoidin domain receptor tyrosine kinase 2 (DDR2), which maintains the growth advantage of tumor cells while activating YAP/TAZ-mediated ferroptosis sensitivity, explaining the higher ferroptosis sensitivity in recurrent tumor cells.